Introduction
============

Ventilator-associated pneumonia (VAP), the most common type of hospital-acquired pneumonia (HAP), is defined as bacterial pneumonia that develops in patients who have received mechanical ventilation for \>48 h ([@b1-mmr-12-05-7455]). VAP occurs in 6--52% of mechanically ventilated patients and in certain specific settings, the incidence is up to 76% ([@b2-mmr-12-05-7455]). The incidence of VAP varies depending on the type of population studied, the intensity of preventive measures implemented and the presence or absence of risk factors. With an estimated attributable mortality of 9%, VAP usually increases the time of mechanical ventilation and time spent in the intensive care unit (ICU) by \>10 days and its treatment accounts for at least 50% of antibiotics prescribed in ICUs, producing a huge cost ([@b3-mmr-12-05-7455]). The expected burden of VAP in the coming years may increase with the increasing age of the population, intensification of care and the growing prevalence of severe underlying diseases in ICU patients ([@b4-mmr-12-05-7455]). As the diagnosis as well as the treatment of VAP remain challenging, studies are required to gain a comprehensive understanding of VAP.

A number of previous studies have shown that up- or down-regulation of the expression of certain genes is closely associated with the development of infection. For instance, a study on the polymorphism of tumor necrosis factor (TNF)-α reported that overexpression of TNF-α is associated with a 2.1-13-fold increase in the incidence of severe sepsis from all causes, including pneumonia ([@b5-mmr-12-05-7455]). *PI3*, which encodes an elastase-specific inhibitor with antimicrobial peptide activity, has proven to promote early clearance of *Pseudomonas aeruginosa* by activating macrophages and recruiting neutrophils ([@b6-mmr-12-05-7455]). *PIK3R3*, which encodes the protein of phosphoinositide 3-kinase regulatory sub-unit gamma, was shown to be predominately expressed in immune cells and to be involved in chemoattractant-induced cell migration ([@b7-mmr-12-05-7455]). None of these genes alone, however, is sufficient enough to answer the fundamental question why certain patients develop VAP, while other similar patients do not.

As a genome-wide screening approach, microarray analysis may be effective for identifying novel genetic factors or gene expression profiles associated with the development of infection in VAP. With the goal to construct a model for the prediction of susceptibility to VAP in critically-injured trauma patients, Swanson *et al* ([@b8-mmr-12-05-7455]) analyzed the gene expression profiles of patients who developed VAP and those who were never affected. By comparing the differentially expressed genes (DEGs) between the two groups, a logistic regression model was constructed, which comprised five genes (*PIK3R3, ATP2A1, PI3, ADAM8* and *HCN4*) and was able to accurately categorize 95% of patients that developed VAP.

The present study identified DEGs between patients with VAP and those without VAP based on the expression profiling data provided by Swanson *et al* ([@b8-mmr-12-05-7455]) and then performed functional annotation and enrichment analyses in order to elucidate the potential molecular mechanisms of VAP. In addition, a protein-protein interaction (PPI) network was constructed and the functional modules in this network were analyzed. The novel view on VAP provided by the present study indicates that VAP requires further study.

Materials and methods
=====================

Derivation of genetic data
--------------------------

The gene expression profile dataset GSE30385 deposited by Swanson *et al* ([@b8-mmr-12-05-7455]) was downloaded from the Gene Expression Omnibus database (<http://www.ncbi.nlm.nih.gov/geo>), a public functional genomics data repository. The annotation platform was the GPL201 (HG-Focus) Affymetrix Human HG-Focus Target Array platform (Affymetrix, Inc., Santa Clara, CA, USA) updated on May 10th, 2013. A total of 20 samples from critically ill trauma patients were available, including 10 patients who developed ventilator-associated pneumonia (VAP group) and 10 who did not (NoVAP group).

Data processing
---------------

The Robust Multichip Average method of the R/Bioconductor Affy package (<http://www.bioconductor.org/>; Affymetrix, Inc.) was used to pre-process the downloaded raw data via background adjustment, quintile normalization and summarization ([@b9-mmr-12-05-7455]). Using the R/Bioconductor software v 3.1 (<http://www.bioconductor.org/>), probe serial numbers in the matrix were transformed into gene names. As certain different probes can be mapped to the same gene, the average probe expression value was calculated as the final expression value of the corresponding gene.

Screening of DEGs
-----------------

To screen DEGs between the VAP group and the NoVAP group, the Linear Models for Microarray Data (Limma) package in R/Bioconductor software 3.1 (<http://www.bioconductor.org/packages/release/bioc/html/limma.html>) was used ([@b10-mmr-12-05-7455]). The Benjamini-Hochberg false discovery rate (FDR) was used to adjust the raw P-value in the multiple testing ([@b11-mmr-12-05-7455],[@b12-mmr-12-05-7455]). DEGs were screened with cutoff values of FDR\<0.05 and \|log (fold change)\|≥1.5 ([@b13-mmr-12-05-7455],[@b14-mmr-12-05-7455]). The eligible DEGs were grouped into upregulated and downregulated genes. To guarantee that the identified DEGs represent the two types of specimen, cluster analysis of DEGs was also performed using the Pheatmap package of R (<http://cran.r-project.org/web/packages/pheatmap/index.html>).

Functional annotation and pathway enrichment analysis
-----------------------------------------------------

The Database for Annotation Visualization and Integrated Discovery (DAVID) provides a comprehensive set of functional annotation tools to understand the biological meaning of large lists of genes by using a hypergeometric distribution algorithm ([@b15-mmr-12-05-7455]). To functionally annotate DEGs identified between the VAP group and the NoVAP group, DAVID was used to analyze the significantly enriched Gene Ontology (GO) terms ([@b16-mmr-12-05-7455]) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways ([@b17-mmr-12-05-7455]) for upregulated and down-regulated genes, respectively (adjusted P-value \<0.05).

Computational identification of transcription factors (TF), tumor suppressor genes (TSGs) and oncogenes
-------------------------------------------------------------------------------------------------------

TRANSFAC version 7.0 (<http://www.gene-regulation.com/pub/databases.html>), which was initially a data collection, has evolved into the basis for a complex platform for the description and analysis of gene regulatory events and networks, including TFs as well as their DNA-binding sites and profiles ([@b18-mmr-12-05-7455]). The TSGene database was designed by integrating TSGs with large-scale experimental evidence to offer a comprehensive resource for further investigation of TSGs and their molecular mechanisms in cancer ([@b19-mmr-12-05-7455]). The tumor-associated gene (TAG) database was developed by integrating information from well-characterized oncogenes and tumor suppressor genes to facilitate cancer research ([@b20-mmr-12-05-7455]). Based on these three databases, DEGs identified between the VAP group and the NoVAP group were analyzed for the screening of TFs, TSGs and TAGs.

Protein-protein interaction (PPI) network construction
------------------------------------------------------

The Search Tool for the Retrieval of Interacting Genes (STRING version 1.0; <http://string-db.org/>) is an online database which includes experimental as well as predicted interaction information and comprises \>1,100 completely sequenced organisms ([@b21-mmr-12-05-7455]). The DEGs identified above were directly mapped to the STRING database for acquiring significant PPI pairs from a range of sources, including data from experimental studies and data retrieved by text mining and homology searches. PPI pairs with the combined score of ≥0.4 were retained for the construction of the PPI network.

Functional module analysis
--------------------------

CFinder (<http://www.cfinder.org/>) is a fast program for locating and visualizing overlapping, densely interconnected groups of nodes (defined as modules) in undirected graphs, and allows for easy navigation between the original graph and the network of these groups ([@b22-mmr-12-05-7455]). Using the default parameter of *k*=3, modules were screened from the PPI network constructed as described above using CFinder. The top two sub-modules identified by modularity analysis were then selected for later functional enrichment by DAVID (FDR\<0.05).

Results
=======

Identification of DEGs
----------------------

With a FDR\<0.05 and \|log (fold change)\|≥1.5, 69 DEGs between the VAP group and the NoVAP group were obtained. Of these DEGs, 33 (47.83%) were upregulated and 36 (52.17%) were downregulated in the VAP group compared with the NoVAP group. The results of the clustering analysis of the DEGs are shown in [Fig. 1](#f1-mmr-12-05-7455){ref-type="fig"}.

Functional annotation and pathway enrichment analysis
-----------------------------------------------------

To identify the functions of these DEGs, all of the up- and downregulated genes were mapped to terms of the GO database, which consists of three ontologies, namely biological processes (BP), cellular components (CC) and molecular function (MF). In the three categories of the GO terms, \'immune system processes\', \'immune response\', \'kinase activity\' were dominant for the upregulated genes, while \'response to stress\', \'programmed cell death\' and \'peptidase inhibitor activity\' were dominant among the downregulated genes ([Table I](#tI-mmr-12-05-7455){ref-type="table"}).

KEGG was used to further identify the altered biological functions arising from these DEGs. The upregulated genes were mainly enriched in ten pathways, including the neurotrophin signaling pathway, the mitogen-activated protein kinase (MAPK) signaling pathway and the nucleotide-binding oligomerization domain (NOD)-like receptor signaling pathway, while the downregulated genes were enriched in nine pathways, which included complement and coagulation cascades as well as pathways in cancer and ribosomes ([Table II](#tII-mmr-12-05-7455){ref-type="table"}).

Identification of TFs, TSGs and oncogenes
-----------------------------------------

According to the TRANSFAC, TSGene and TAG databases, a total of four TFs, two oncogenes, four TSGs and two other TAGs were further screened from the DEGs preliminarily identified between the VAP group and the NoVAP group ([Table III](#tIII-mmr-12-05-7455){ref-type="table"}).

PPI construction
----------------

The PPI network contained 64 PPI pairs and 44 nodes (20 upregulated genes and 24 downregulated genes in the VAP group) ([Fig. 2](#f2-mmr-12-05-7455){ref-type="fig"}). The five node proteins with a connection degree of \>5 were ELANE (connection degree, 10), PTGS2 (connection degree, 9), MAPK14 (connection degree, 8), LTF (connection degree, 7) and MMP8 (connection degree, 6).

Functional module analysis
--------------------------

High aggregation, which reflects the high modularization of a gene network, is an important characteristic of biological networks. To distinguish the modules with specific functions and different sizes, the constructed network was usually divided into relatively independent sub-modules prior to analysis. By using CFinder, three models were obtained using the default parameter of *k*=3 and the top two modules are shown in [Fig. 3](#f3-mmr-12-05-7455){ref-type="fig"}.

The significantly enriched GO terms and KEGG pathways for Module 1 and Module 2 are displayed in [Tables IV](#tIV-mmr-12-05-7455){ref-type="table"} and [V](#tV-mmr-12-05-7455){ref-type="table"}, respectively. Genes in Module 1 were mainly classified into the GO terms of multi-organism processes, extracellular region and serine-type endopeptidase activity, while genes in Module 2 were mainly classified into the GO terms negative regulation of biological processes, nucleus and protein kinase activity. Genes in Module 2 were enriched in 12 pathways, including the MAPK, p53 and VEGF signaling pathways, while no significant pathway was identified for genes in Module 1 at FDR\<0.05.

Discussion
==========

Due to its high prevalence and mortality, there is an urgent requirement to investigate the pathogenic mechanism of VAP. The present study analyzed the gene expression profiles of patients who developed VAP and those who were not affected in order to identify possible functions and signaling pathways of DEGs between the two groups. After the construction of a PPI network, sub-modules in the network were mined and the functions of the top two modules were annotated.

In the present study, a total of 69 DEGs were identified between patients with VAP and those not affected. This result differs from that of Swanson *et al* ([@b8-mmr-12-05-7455]), who provided the gene expression profile and identified 810 DEGs between the two groups. The inconsistency between the present study and that by Swanson *et al* ([@b8-mmr-12-05-7455]) is likely to be attributed to the different statistical methods employed for detecting DEGs. Swanson *et al* ([@b8-mmr-12-05-7455]) screened the DEGs using Partek software and the analysis of variance method, which calculates a *q*-value as described by Storey and Tibshirani ([@b23-mmr-12-05-7455]), while the present study used the Limma package in R language, which is at present most commonly applied for identifying DEGs. To avoid false-positive results, relatively high cutoff values of FDR\<0.05 and \|log (fold change)\|≥1.5 were set, which ensured high accuracy of the results.

The upregulated genes in the VAP group identified in the present study were mainly enriched in the GO terms of immune system processes and immune responses, which have been verified to have a pivotal role in the development of VAP ([@b24-mmr-12-05-7455]). The immune system has a central role in controlling the duration and amplitude of the inflammatory response ([@b25-mmr-12-05-7455]). A previous study on sepsis revealed that the innate and adaptive immune response is considerably different between patients with VAP and those without this type of nosocomial infection ([@b26-mmr-12-05-7455]). A cohort study including 90 patients with VAP mainly caused by Gram-negative bacteria demonstrated an association between immune system disorders and mortality, as patients with early monocyte apoptosis of \>50% were less likely to succumb to sepsis compared with those exhibiting monocyte apoptosis of l\<50% ([@b27-mmr-12-05-7455]). The present study revealed that GO:0002376 (immune system processes) and GO:0006955 (immune responses) were significantly abnormal in patients with VAP, and the two GO categories included the genes *ELANE* and *LTF*. *ELANE* is the gene encoding neutrophil elastase, a serine protease expressed in myelomonocytic cells and their precursors ([@b28-mmr-12-05-7455]). Mutations in the *ELANE* gene are proven to be the most common genetic cause of congenital neutropenia, as *ELANE* mutations are associated with functional deficiencies in neutrophils and further contribute to the risk of infection ([@b29-mmr-12-05-7455],[@b30-mmr-12-05-7455]). In addition, lactoferrin, encoded by *LTF*, was suggested to affect the regulation of the inflammatory response by modulating cellular iron homeostasis ([@b31-mmr-12-05-7455]). Furthermore, the present study showed that *ELANE* and *LTF* were the significant nodes in the resulting PPI network. It is therefore inferred that *ELANE* and *LTF* may be involved in the susceptibility of patients to VAP by affecting the immune response.

The present study also observed that the upregulated genes in patients with VAP were significantly enriched in the MAPK signaling pathway, which was also the most significant pathway enriched among genes in Module 2 mined from the PPI network. The MAPK signaling pathway is a three-tiered cascade that includes a MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAP2K) and MAPK, which regulate numerous cellular functions, including proliferation, differentiation, migration and apoptosis ([@b32-mmr-12-05-7455]). The four major MAPKs are extracellular regulated kinases 1 and 2 (ERK1/2), c-Jun-N-terminal kinases, p38 and ERK5 ([@b33-mmr-12-05-7455]). Functional analysis performed in the present study demonstrated that four DEGs (*GADD45A, MAPK14, IL1R2* and *MAP2K6*) were significantly enriched in this pathway, among which *MAPK14* is also one of the nodes with the highest connection degree in the PPI network. *MAPK14* encodes the MAPK14 protein that is also referred to as p38α ([@b34-mmr-12-05-7455]). p38α is the first identified member of the p38 MAPK family and can be targeted by pyridinylimidazole drugs that inhibit the production of pro-inflammatory cytokines ([@b35-mmr-12-05-7455]). Höcker *et al* ([@b36-mmr-12-05-7455]) have demonstrated that following its activation by the GADD45B-MAP3K4 signaling complex, MAPK14 is directed to autophagosomes, where it impairs autophagosome-lysosome fusion and thus autophagy. It has been indicated that activation of autophagy in macrophages mediates the early lung inflammation during mechanical ventilation via NLRP3 inflammasome signaling ([@b37-mmr-12-05-7455]). These findings combined with the results of the present study lead to the hypothesis that the p38 MAPK signaling pathway may be involved in the development of VAP and *MAPK14* may be one of the key genes in this process.

In conclusion, the present study analyzed the gene expression profiles between patients with VAP and those not affected by this disease using a computational bioinformatics approach. Functional annotation of the DEGs into GO terms and KEGG pathways was performed, and a PPI network was constructed, followed by module mining. Genes including *ELANE*, *LTF* and *MAPK14* may have important roles in the development of VAP via altering the immune response and the MAPK signaling pathway. The present study provided a novel, genetic perspective on VAP, which may aid in the development of strategies to prevent or treat VAP in patients in ICUs.

The present study was supported by the Nosocomial Infection Control Research Fund of The Chinese Preventative Association (grant no. ZHYG2014-0037) and the Jinling Hospital Research Fund of the Jinling Affiliated Hospital of Nanjing University Medical School (grant no. YYMS2014017).

![Dendrogram of differentially expressed genes identified by cluster analysis.](MMR-12-05-7455-g00){#f1-mmr-12-05-7455}

![Protein-protein interaction networks of differentially expressed genes.](MMR-12-05-7455-g01){#f2-mmr-12-05-7455}

![Top two modules in the protein-protein interaction network.](MMR-12-05-7455-g02){#f3-mmr-12-05-7455}

###### 

Classification of differentially expressed genes in ventilator-associated pneumonia according to GO terms with P\<0.05.

  Gene category         GO ID        Function                                            Count   P-value
  --------------------- ------------ --------------------------------------------------- ------- -------------
  Upregulated genes                                                                              
   BP                   GO:0009617   Response to bacterium                               9       6.66×10^−8^
                        GO:0006955   Immune response                                     14      2.12×10^−7^
                        GO:0051707   Response to other organism                          9       5.28×10^−6^
                        GO:0009607   Response to biotic stimulus                         9       7.59×10^−6^
                        GO:0002376   Immune system process                               15      9.69×10^−6^
   CC                   GO:0005576   Extracellular region                                13      0.0001
                        GO:0071682   Endocytic vesicle lumen                             2       0.0004
                        GO:0030139   Endocytic vesicle                                   4       0.0005
                        GO:0005615   Extracellular space                                 6       0.0052
                        GO:0045335   Phagocytic vesicle                                  2       0.0076
   MF                   GO:0004908   Interleukin-1 receptor activity                     2       8.24×10^−5^
                        GO:0035251   UDP-glucosyltransferase activity                    2       0.0001
                        GO:0046527   Glucosyltransferase activity                        2       0.0002
                        GO:0004708   Kinase activity                                     2       0.0005
                        GO:0004712   Protein serine/threonine/tyrosine kinase activity   2       0.0023
  Downregulated genes                                                                            
   BP                   GO:0050873   Brown fat cell differentiation                      3       5.08×10^−5^
                        GO:0006950   Response to stress                                  18      0.0001
                        GO:0050790   Regulation of catalytic activity                    12      0.0001
                        GO:0006915   Apoptotic process                                   12      0.0002
                        GO:0012501   Programmed cell death                               12      0.0002
   CC                   GO:0044445   Cytosolic part                                      4       0.0005
                        GO:0022626   Cytosolic ribosome                                  3       0.0009
                        GO:0044421   Extracellular region part                           8       0.0019
                        GO:0044391   Ribosomal subunit                                   3       0.0026
                        GO:0005829   Cytosol                                             12      0.0036
   MF                   GO:0042277   Peptide binding                                     4       0.0004
                        GO:0033218   Amide binding                                       4       0.0005
                        GO:0004866   Endopeptidase inhibitor activity                    4       0.0006
                        GO:0061135   Endopeptidase regulator activity                    4       0.0006
                        GO:0030414   Peptidase inhibitor activity                        4       0.0006

GO, gene ontology; BP, biological process; CC, cellular components; MF, molecular function.

###### 

Enrichment of KEGG pathways in ventilator-associated pneumonia with P\<0.05.

  Gene category         KEGG ID   Function                                     Count   P-value
  --------------------- --------- -------------------------------------------- ------- ---------
  Upregulated genes     4722      Neurotrophin signaling pathway               3       0.0064
                        4010      Mitogen-activated protein kinase signaling   4       0.0078
                        5014      Amyotrophic lateral sclerosis                2       0.0112
                        4621      Nucleotide-binding oligomerization domain    2       0.0133
                                  receptor signaling pathway                           
                        4664      Fc epsilon RI signaling pathway              2       0.0238
                        4640      Hematopoietic cell lineage                   2       0.0291
                        4912      Gonadotropin-releasing hormone signaling     2       0.0375
                        4620      Toll-like receptor signaling pathway         2       0.0382
                        5146      Amoebiasis                                   2       0.0410
                        4060      Cytokine-cytokine receptor interaction       3       0.0449
  Downregulated genes   4610      Complement and coagulation cascades          4       0.0001
                        3010      Ribosome                                     3       0.0053
                        5150      *Staphylococcus aureus* infection            2       0.0192
                        5131      Shigellosis                                  2       0.0234
                        5140      Leishmaniasis                                2       0.0318
                        5220      Chronic myeloid leukemia                     2       0.0326
                        5200      Pathways in cancer                           4       0.0358
                        5222      Small cell lung cancer                       2       0.0431
                        4012      ErbB signaling pathway                       2       0.0449

KEGG, Kyoto Encyclopedia of Genes and Genomes.

###### 

Annotation for TFs, TSGs, oncogenes and other TAGs in ventilator-associated pneumonia.

  Gene category         TFs                 Oncogenes   TSGs                 Other TAGs
  --------------------- ------------------- ----------- -------------------- ------------
  Upregulated genes     KLF7                CD24        LTF                  NA
  Downregulated genes   EGR3, FOSB, NCOR2   CRK         BTG2, CDKN1A, THBD   RGS2, CTSZ

TF, transcription factor; TSG, tumor suppressor gene; TAG, tumor-associated gene.

###### 

GO annotation for genes in the top two modules.

  Category   GO ID        Function                                                           Count   P-value
  ---------- ------------ ------------------------------------------------------------------ ------- -------------
  Module 1                                                                                           
   BP        GO:0050832   Defense response to fungus                                         3       3.87×10^−7^
             GO:0009620   Response to fungus                                                 3       1.42×10^−6^
             GO:0009617   Response to bacterium                                              5       1.96×10^−6^
             GO:0051704   Multi-organism process                                             7       5.46×10^−6^
             GO:0051707   Response to other organisms                                        5       2.53×10^−5^
   CC        GO:0005576   Extracellular region                                               9       8.31×10^−8^
             GO:0031012   Extracellular matrix                                               3       0.0016
             GO:0044421   Extracellular region part                                          4       0.0031
             GO:0030141   Secretory granule                                                  2       0.0103
             GO:0005615   Extracellular space                                                3       0.0114
   MF        GO:0004252   Serine-type endopeptidase activity                                 3       5.05×10^−5^
             GO:0008236   Serine-type peptidase activity                                     3       7.44×10^−5^
             GO:0017171   Serine hydrolase activity                                          3       7.70×10^−5^
             GO:0004175   Endopeptidase activity                                             3       0.0007
             GO:0004867   Serine-type endopeptidase inhibitor activity                       2       0.00103
  Module 2                                                                                           
   BP        GO:0071478   Cellular response to radiation                                     4       4.48×10^−7^
             GO:2000379   Positive regulation of reactive oxygen species metabolic process   3       9.14×10^−7^
             GO:0048519   Negative regulation of biological processes                        9       1.27×10^−6^
             GO:0009605   Response to external stimuli                                       7       1.63×10^−6^
             GO:0071479   Cellular response to ionizing radiation                            3       2.02×10^−6^
   CC        GO:0005634   Nucleus                                                            7       0.0038
             GO:0005654   Nucleoplasm                                                        3       0.0219
   MF        GO:0004708   Mitogen-activated protein kinase kinase activity                   2       3.65×10^−5^
             GO:0004712   Protein serine/threonine/tyrosine kinase activity                  2       0.00018
             GO:0004672   Protein kinase activity                                            3       0.0038
             GO:0016773   Phosphotransferase activity, alcohol group as acceptor             3       0.0064
             GO:0016301   Kinase activity                                                    3       0.0079

GO, gene ontology; BP, biological process; CC, cellular components; MF, molecular function.

###### 

KEGG pathway enrichment for genes in Module 2.

  KEGG ID   Function                                               Count   P-value
  --------- ------------------------------------------------------ ------- ---------
  4380      Osteoclast differentiation                             3       0.0005
  5014      Amyotrophic lateral sclerosis                          2       0.0022
  4115      P53 signaling pathway                                  2       0.0035
  5140      Leishmaniasis                                          2       0.0040
  4370      Vascular endothelial growth factor signaling pathway   2       0.0044
  4010      Mitogen-activated protein kinase signaling pathway     3       0.0044
  4664      Fc epsilon RI signaling pathway                        2       0.0048
  4912      Gonadotropin-releasing hormone signaling pathway       2       0.0077
  4620      Toll-like receptor signaling pathway                   2       0.0078
  4110      Cell cycle                                             2       0.0114
  5145      Toxoplasmosis                                          2       0.0129
  5160      Hepatitis C                                            2       0.0132

KEGG, Kyoto Encyclopedia of Genes and Genomes.
